Friday, October 9, 2015: 12:30 PM-2:00 PM
Room: Poster Hall
Learning Objectives:
-
Tracks: Adult ID, Investigative ID
Presentations:
Ecological Effect of Ceftaroline/Avibactam on the Normal Human Intestinal Microbiota
Carl Erik Nord, PhD, MD, FIDSA
;
Mamun-Ur Rashid, MD, PhD
;
Staffan Rosenborg, MD, PhD
;
Georgios Panagiotidis, MD, PhD
;
Karin Söderberg Löfdal, MD, PhD
;
Andrej Weintraub, PhD
Exploratory analysis of the plasma metagenome reveals no difference between individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and healthy controls
Ruth Miller, DPhil
;
Jennifer Gardy, PhD
;
Shoshana Parker, BSc
;
Theodore Steiner, MD
;
Vincent Montoya, MSc
;
Patrick Tang, M.D., Ph.D., FRCPC
;
David M. Patrick, MD, MHSc, FRCPC
Breastfeeding influences establishment and development of the infant microbiome
Pia S. Pannaraj, MD, MPH
;
Fan Li, PhD
;
Chiara Cerini, MD
;
Jeffery Bender, MD
;
Kyle Bittinger, PhD
;
Aubrey Bailey, PhD
;
Adrienne Rollie, MS
;
Helty Adisetiyo, PhD
;
Chintda Santiskulvong, PhD
;
Frederic Bushman, PHD
;
John Sleasman, MD
;
Grace Aldrovandi, MD, PhD
Expanded Enteric Virome and Altered Bacterial Microbiome in AIDS
Cynthia Monaco, M.D., Ph.D.
;
David Gootenberg, B.A.
;
Guoyan Zhao, Ph.D.
;
Efrem Lim, Ph.D.
;
Musie Ghebremichael, Ph.D.
;
Megan Baldridge, M.D., Ph.D.
;
Craig Wilen, M.D., Ph.D.
;
Scott Handley, Ph.D.
;
Meaghan Flagg, B.S.
;
Mark Siedner, M.D. M.P.H.
;
Jason Norman, Ph.D.
;
Brian Keller, M.D., Ph.D.
;
Alexander Lankowski, M.A.
;
David Wang, Ph.D.
;
Douglas Kwon, M.D., Ph.D.
;
Herbert Virgin, M.D., Ph.D.
Comparison of Stool versus Rectal Swab Samples from Long-Term Acute Care Hospital (LTACH) Patients for Microbiota Analysis
Christine M. Bassis, PhD
;
Anna Seekatz, PhD
;
Nicholas M. Moore, MS
;
Karen Lolans, BS
;
Robert a. Weinstein, MD, FIDSA, FSHEA
;
Vincent B. Young, MD/PhD, FIDSA
;
Mary K. Hayden, MD, FIDSA, FSHEA
;
For the CDC Prevention Epicenters Program, .
Vancomycin-resistant enterococcal (VRE) titers diminish among patients with recurrent Clostridium difficile infection after administration of SER-109, a novel microbiome agent
Mary-Jane Lombardo, PhD
;
Marin Vulic, PhD
;
Toshi Ohsumi, PhD
;
David Cook, PhD
;
Matthew Henn, PhD
;
Colleen Kraft, MD
;
Sahil Khanna, MBBS, MS
;
Darrell Pardi, MD, MS
;
Elizabeth Hohmann, MD, FIDSA
DAV132, an Adsorbent-Based Product, Protects the Gut Microbiome and Prevents Clostridium difficile Infections during Moxifloxacin Treatments
Jean De Gunzburg, PhD
;
Amine Ghozlane, PhD
;
Annie Ducher, MD
;
Xavier Duval, MD, PhD
;
Etienne Ruppé, PharmD, PhD
;
Mark Pulse, MS
;
Caroline Chilton, PhD
;
Laurence Armand-Lefevre, PharmD, PhD
;
Elisabeth Chachaty, PharmD, PhD
;
Sakina Sayah-Jeanne, PhD
;
Joël Doré, PhD
;
Emmanuelle Le Chatelier, PhD
;
Florence Levenez, BS
;
Sean Kennedy, PhD
;
Nicolas Pons, PhD
;
William Weiss, MS
;
Mark Wilcox, MD
;
France Mentré, MD, PhD
;
Antoine Andremont, MD, PhD
;
Stanislav Dusko Ehrlich, PhD
Autologous fecal microbiota transplantation as a strategy to prevent colonization with multi-drug resistant organisms following antimicrobial therapy
Christopher Bulow, BA
;
Alaric D'souza, BS
;
Tiffany Hink, BS
;
Meghan Wallace, BS
;
Kimberly Reske, MPH
;
Xiaoqing Sun, MS
;
Jennie H. Kwon, D.O.
;
Carey-Ann D. Burnham, PhD
;
Gautam Dantas, PhD
;
Erik R. Dubberke, MD, MSPH, FIDSA, FSHEA
CME Credits:
ACPE Credits:
ACPE Number: